FDA 执法报告 D-0168-2027 记录 Fresenius DELFLEX 腹膜透析液因无菌保证不足的自愿召回
FDA drug enforcement D-0168-2027: Fresenius Medical Care Renal Therapies Group, LLC — Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.
FDA 执法报告 D-0168-2027 记录 Fresenius Medical Care Renal Therapies Group 自愿召回 DELFLEX 腹膜透析液,分级为 Class II。
记录列明受影响批号、有效期及美国全国分销范围,可用于核对本次召回涉及的批次边界与无菌保证缺陷描述。
FDA 药品召回执行报告 — D-0168-2027
报告发布日期:2026-11-11。这是执行报告的日期,不是召回启动日期。
范围:一条已分类的药品召回记录;event_id 可能归组多个产品。没有召回编号的未分类记录不在本数据流范围内。本记录不是新闻稿,也不是新的执法认定。
openFDA 数据集每周更新。报告状态不是实时召回状态,不得用于跟踪召回生命周期。以下其他日期保留其各自名称所对应的含义。
完整的官方产品记录(包括 openFDA 统一标识符):
{
"address_1": "350 Merrimack St",
"address_2": "",
"center_classification_date": "20261103",
"city": "Lawrence",
"classification": "Class II",
"code_info": "Lot # 25DGPD002, 25DGPD003, Exp 10/31/2026; 25KGPD027, 25KGPD042, Exp 2/28/2027; 25SGPD033, Exp 6/30/2027; 26AGPD033, 26AGPD054, Exp 7/31/2027.",
"country": "United States",
"distribution_pattern": "Nationwide in the USA.",
"event_id": "100130",
"initial_firm_notification": "Letter",
"more_code_info": "",
"openfda": {
"application_number": [
"NDA020171"
],
"brand_name": [
"DELFLEX"
],
"generic_name": [
"DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"
],
"is_original_packager": [
true
],
"manufacturer_name": [
"Fresenius Medical Care de Mexico, S.A. de C.V."
],
"package_ndc": [
"46163-209-92",
"46163-209-94",
"46163-209-95",
"46163-212-95",
"46163-212-92",
"46163-212-94",
"46163-206-92",
"46163-206-94",
"46163-206-95"
],
"product_ndc": [
"46163-206",
"46163-209",
"46163-212"
],
"product_type": [
"HUMAN PRESCRIPTION DRUG"
],
"route": [
"INTRAPERITONEAL"
],
"spl_id": [
"5f14959c-adcd-923c-e063-6294a90ab6de"
],
"spl_set_id": [
"a98facd6-9daa-4d37-8209-63a0599dbfaa"
],
"substance_name": [
"DEXTROSE MONOHYDRATE",
"SODIUM CHLORIDE",
"SODIUM LACTATE",
"CALCIUM CHLORIDE",
"MAGNESIUM CHLORIDE"
],
"unii": [
"TU7HW0W0QT",
"LX22YL083G",
"02F3473H9O",
"451W47IQ8X",
"M4I0D6VV5M"
]
},
"postal_code": "01843-1748",
"product_description": "DELFLEX 含 2.5% 葡萄糖、低镁/低钙的腹膜透析液,附带 stay safe 交换装置,2,000 mL 单剂量袋,无菌、无热原,仅限处方,CAT. No. 054-20222。Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843。NDC 46163-209-92",
"product_quantity": "6,283 箱(每箱 5 袋)",
"product_type": "Drugs",
"reason_for_recall": "无菌保证不足:已收到投诉,涉及受影响批次主袋印刷区域的小穿孔可能导致泄漏。",
"recall_initiation_date": "20261014",
"recall_number": "D-0168-2027",
"recalling_firm": "Fresenius Medical Care Renal Therapies Group, LLC",
"report_date": "20261111",
"state": "MA",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov